Notification and current-status evidence
The sent-report ledger records the first outgoing report at . A report was sent to the recorded registrar; contact details remain in Domain Intelligence. The latest stored availability evidence still shows the domain reachable; 5 months has elapsed since the first outgoing report.
ICANN RAA §3.18 describes registrar abuse-contact and handling obligations. This section records outgoing timestamps and later availability. It does not by itself prove receipt, acknowledgement, investigation, remediation, or contractual non-compliance.
purepharmas[.]com
“Research-Grade Peptides”
साक्ष्य सारांश
The domain purepharmas.com was registered on March 11, 2026 and is hosted on IP 193.23.118.89, which belongs to ASN AS214036 (Ultahost, Inc.) and resolves to the Netherlands. The authoritative nameservers are elliott.ns.cloudflare.com and may.ns.cloudflare.com, and the site presents a valid Let’s Encrypt R13 TLS certificate. The landing page returns HTTP 200 and carries the title “Research-Grade Peptides,” suggesting a fabricated pharmaceutical front.
Infrastructure analysis shows a WordPress stack backed by MySQL, PHP, Yoast SEO, Apache HTTP Server, Underscore.js, Swiper, and reCAPTCHA. An MX record for mail.purepharmas.com is present with priority 0, indicating a functional mail subsystem. The domain’s Gridinsoft trust score is 0 / 100, and VirusTotal reports a single vendor detection out of 95 scanners. The domain appears on one external blocklist and is already listed by PhishDestroy as malicious.
Threat assessment identifies a high‑risk brand‑impersonation campaign targeting the “compound” brand, with the profile labeled as a cryptocurrency scam. The site’s content and language are crafted to lure victims into purchasing purported research‑grade peptides, likely to harvest cryptocurrency payments. While the exact payment mechanisms are not visible in the current snapshot, the presence of reCAPTCHA and a legitimate TLS certificate suggests an attempt to appear trustworthy and evade automated detection.
Defenders should immediately block purepharmas.com at DNS and proxy layers, enforce email filtering for the associated MX host, and monitor for any outbound connections to the 193.23.118.89 address. Continuous scanning of related Cloudflare‑served subdomains is advised, as is the deployment of sinkhole redirects for any future resolution attempts. Given the active status and high risk rating, organizations should also alert users about the fraudulent “Research‑Grade Peptides” offering and reinforce policies against unsolicited cryptocurrency payment requests.
भेजे गए प्रमाण का स्नैपशॉट
- भेजा गया
- लेज़र रिकॉर्ड
- 1
- केस आईडी
PD-20260311-F97AB5- कैप्चर किए गए पेज का शीर्षक
- Research-Grade Peptides & High-Purity Research Compounds
- PDF दस्तावेज़
- PDF प्रमाण
कानूनी आधार
प्रमाण का पूरा पाठ
Illegal Activities: Active phishing operation targeting victims
Fraud & Deception: Impersonation of legitimate services
Identity Theft: Collection of credentials under false pretenses
Applicable Laws (IS):
International Anti-Cybercrime Regulations
Budapest Convention on Cybercrime
Universal Fraud Prevention Laws
Phishing activities violate international cybercrime conventions and IS's domestic fraud laws.
Action Required: This evidence-backed report demonstrates clear violations requiring suspension per your policies. Continued hosting exposes your organization to regulatory scrutiny and potential legal liability.
Data Coverage
नेटवर्क सुरक्षा इंटेलिजेंस
| Detection System | Indicator | Verdict | Alert |
|---|---|---|---|
| DNS4EU | purepharmas.com |
malicious | Sinkholed |
धमकी प्रतिक्रिया पाइपलाइन
ब्लॉकलिस्ट कवरेज
10 निगरानी वाले बाहरी स्रोत · संग्रहीत स्नैपशॉट 11/08/2026
पहचान समयरेखा
-
VirusTotal
0 → 1
सहेजा गया कैप्चर
डोमेन इंटेलिजेंस
तकनीकी विवरणDNS, TLS नाम और समय-मुद्राएँ
ICANN OVERSIGHT
प्रत्यायन और आरएए संदर्भ
प्रत्यायन और आरएए संदर्भ
Registrar accreditation and DNS abuse obligations
For this gTLD, the registrar above operates under an ICANN accreditation agreement. The links below provide the official fee schedule and current DNS abuse compliance guidance.
Accreditation is a contract, not a safety certification.
RAA §3.18 establishes abuse-contact and handling requirements. This report can document stored outbound notices and later technical observations; it does not by itself establish receipt, investigation, remediation, or contractual non-compliance.
वायरसटोटल विश्लेषण
साइट प्रदर्शन विश्लेषण
Google PageSpeed Insights — mobile performance audit of purepharmas.com · checked Mar 11, 2026
क्या आप इस साइट से प्रभावित हुए?
यदि आपने खाता क्रेडेंशियल, व्यक्तिगत या भुगतान जानकारी दर्ज की है, या इस डोमेन से कोई फ़ाइल डाउनलोड की है, तो तुरंत कार्रवाई करें। घटना की रिपोर्ट करने और अपनी सुरक्षा करने में आपकी सहायता के लिए नीचे संसाधन दिए गए हैं।
अपने स्थानीय अधिकारियों को रिपोर्ट करें
आधिकारिक साइबर अपराध संपर्क, या एक शिकायत ड्राफ्ट बनाएं → प्राप्त करने के लिए अपना देश चुनें।
किसी भी डोमेन की जाँच करें
संग्रहीत ब्लॉकलिस्ट, WHOIS, DNS और सार्वजनिक स्कैन साक्ष्य का उपयोग करके खतरे का विश्लेषण
अभी स्कैन करेंफ़िशिंग की रिपोर्ट करें
संदिग्ध डोमेन हमारे थ्रेट डेटाबेस में जमा करें — समुदाय की सुरक्षा करें
रिपोर्ट करेंसीधा खतरा फीड
हाल की फ़िशिंग रिपोर्टें और उपलब्धता में परिवर्तन देखे गए
निगरानी करेंजानकारी में रहें, सुरक्षित रहें
लाइव खतरों की निगरानी करें या यदि आपको लगता है कि यह एक गलत सकारात्मक है तो इस लिस्टिंग को चुनौती दें।